Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids

NCT04391621 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.

NCT NCT04391621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Autologous Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids
Lead sponsor
Makerere University
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2021
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adipose derived stem cells, keloid